The MS cohort was stratified for the well-known MHC susceptibility factor DRB1*1501 and the difference between DRB1*1501+ patients and healthy controls was even stronger than in the unconditioned analysis (Table 4). Here, HLA-DRB1 is linked to myeloid sarcoma.